Document is current
Any future updates will be listed below
-
Authors
Collet, Aurore https://orcid.org/0000-0002-8279-1912
de Chambure, Diane Pelletier
Moitrot, Emmanuelle
Breyne, Gaëlle
Mirgot, Floriane
Rogeau, Stéphanie
Tronchon, Mathieu
Nicolas, Amélie
Sanges, Sébastien
Stabler, Sarah
Ledoult, Emmanuel
Terriou, Louis
Launay, David
Hachulla, Eric
Labalette, Myriam
Dubucquoi, Sylvain
Lefèvre, Guillaume
-
Funding
Funding for this research was provided by:
Centre Hospitalier Universitaire de Lille
- License Information
-
More Information
Article History
Accepted: 12 October 2024
First Online: 22 October 2024
Declarations
:
: In line with French recommendations, no ethical approval was requested for this non-interventional study (MR-004 reference methodology). The data and the patients’ sample collections were declared to the CNIL (DEC24-089).
: In line with the regulations laid down by the French National Data Protection Commission (CNIL) and international guidelines, written, informed consent was neither required nor requested for this non-interventional study. The patients received by mail an information letter about the study and a non-opposition notice, and had the opportunity to refuse their inclusion.
: No identifying individual participants’ data are included in this manuscript.
: Guillaume Lefèvre has received honoraria for serving on the board and for participating in symposia from Takeda, LFB, Griffols, research support from LFB, Takeda, CSL Behring, Biotest, Octapharma. David Launay has received honoraria for board or symposia from Takeda, Biocryst, Astra-Zeneca and CSL Behring, and research support from CSL Behring, and Octapharma. Emmanuel Ledoult has received consulting and personal fees from Takeda, Grifols, GSK and Astra-Zeneca.
